Novel thiazole derivatives: a patent review (2008 - 2012. Part 2). (Q38205485)

31 August 2017

title

Novel thiazole derivatives: a patent review (2008 - 2012. Part 2). (English)

1 reference

31 August 2017

Alberto Leoni

0 references

Alessandra Locatelli

1 reference

31 August 2017

Rita Morigi

series ordinal

1 reference

31 August 2017

Mirella Rambaldi

series ordinal

1 reference

31 August 2017

language of work or name

English

0 references

publication date

19 April 2014

1 reference

Expert Opinion on Therapeutic Patents

31 August 2017

published in

1 reference

31 August 2017

1 reference

31 August 2017

1 reference

31 August 2017

page(s)

759-777

1 reference

Novel thiazole derivatives: a patent review (2008 - 2012; Part 1).

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

5HT(6) receptor antagonists: a patent update. Part 1. Sulfonyl derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

5-HT(6) receptor modulators: a patent update. Part 2. Diversity in heterocyclic scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Latest advances in cannabinoid receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Selective cannabinoid receptor 2 modulators: a patent review 2009--present

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Dopamine D3 receptor antagonists: a patent review (2007 - 2012).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

The GABA type A receptor alpha5 subunit gene is associated with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

A linkage disequilibrium map of the 1-Mb 15q12 GABA(A) receptor subunit cluster and association to autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Neurofibromin regulation of ERK signaling modulates GABA release and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTX

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Nicotinic acetylcholine receptors and the regulation of neuronal signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Brain neuronal nicotinic receptors as new targets for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Targeting the alpha9alpha10 nicotinic acetylcholine receptor to treat severe pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Pharmacological agents acting at subtypes of metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Metabotropic glutamate receptor 4 (mGlu4)-positive allosteric modulators for the treatment of Parkinson's disease: historical perspective and review of the patent literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Exploring mechanisms underlying extinction of cue-elicited cocaine seeking

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Adenosine receptors as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Adenosine A1 receptor antagonist improves intradialytic hypotension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Pharmacological and biochemical characterization of purified A2a adenosine receptors in human platelet membranes by [3H]-CGS 21680 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Highly potent and selective ligands for histamine H3-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Therapeutic potential of histamine H3 receptor agonists and antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Pharmacological and molecular characterization of P2X receptors in rat pelvic ganglion neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

ATP-gated ion channel P2X(3) is increased in human inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

EDG1 is a functional sphingosine-1-phosphate receptor that is linked via a Gi/o to multiple signaling pathways, including phospholipase C activation, Ca2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibitio

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Structural and functional characteristics of S1P receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Sphingosine-1-phosphate signaling in physiology and diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Selecting against S1P3 enhances the acute cardiovascular tolerability of 3-(N-benzyl)aminopropylphosphonic acid S1P receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

The complement receptor 3, CR3 (CD11b/CD18), on T lymphocytes: activation-dependent up-regulation and regulatory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Abnormalities in G protein-coupled signal transduction pathways in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Molecular genetics of human visual pigments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Free fatty acids inhibit serum deprivation-induced apoptosis through GPR120 in a murine enteroendocrine cell line STC-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Review article: a comparison of glucagon-like peptides 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Biology and therapeutic applications of peroxisome proliferator- activated receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008-present).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.910196

10.1517/13543776.2014.910196

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference